Sector Watch: Healthcare - May 09 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $103.79 +1.38 1.35% | XBI: $89.80 +1.73 1.96% | Updated May 09, 2018 04:13 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| OPK Opko Health Inc $2.4B |
4.16+0.94 15.7 M 4.4x |
29% | ||
| ARWR52WH Arrowhead Pharmaceuticals $783.1M |
9.00+1.25 5.5 M 4.5x |
16% | ||
| BLCM Bellicum Pharmaceuticals $330.3M |
7.93+1.07 1.9 M |
16% | ||
| CERS52WH Cerus $837.5M |
6.29+0.82 3.9 M 5.0x |
15% | ||
| RGNX52WH REGENXBIO $1.4B |
45.00+5.35 1.0 M 2.0x |
13% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| CUTR Cutera $517.3M |
39.03-16.82 1.6 M 9.9x |
-30% | ||
| CVRS Corindus Vascular Robotics $155.6M |
0.80-0.26 3.5 M 5.6x |
-24% | ||
| PLSE Pulse Biosciences Inc $296.2M |
17.30-2.68 309.3 K |
-13% | ||
| SBOT Stellar Biotechnologies $50.0M |
5.66-0.84 70.1 K 3.8x |
-13% | ||
| ZFGN Zafgen $169.5M |
6.50-0.90 169.0 K |
-12% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
REGENXBIO to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference [prnewswire.com]Pulse Biosciences Quarterly Investor Conference Call | Business Wire [businesswire.com]
Corindus Reports First Quarter 2018 Results | Business Wire [businesswire.com]
Cerus Corporation Reports First Quarter 2018 Results | Business Wire [businesswire.com]
Arrowhead Pharmaceuticals Reports Fiscal 2018 Second Quarter Results | Business Wire [businesswire.com]
REGENXBIO Reports First Quarter 2018 Financial Results and Recent Operational Highlights [prnewswire.com]
Pulse Biosciences Quarterly Investor Conference Call [businesswire.com]
Zafgen Reports First Quarter 2018 Operating and Financial Results [globenewswire.com]
OPKO Health Reports First Quarter 2018 Financial Results [globenewswire.com]
Cutera Reports First Quarter 2018 Financial Results [globenewswire.com]
Cerus Corporation Reports First Quarter 2018 Results [businesswire.com]
Bellicum Pharmaceuticals Reports First Quarter 2018 Financial Results Nasdaq:BLCM [globenewswire.com]
AveXis Reports First Quarter 2018 Financial and Operating Results [globenewswire.com]
Cerus to Present at the Deutsche Bank 43rd Annual Health Care Conference on Wednesday May 9, 2018 | Business Wire [businesswire.com]
Zafgen to Present at Deutsche Bank 43rd Annual Health Care Conference [globenewswire.com]
OPKO Health to Announce First Quarter 2018 Financial Results on May 8, 2018 [globenewswire.com]
Zafgen to Host Conference Call to Discuss First Quarter 2018 Financial Results [globenewswire.com]
REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2018 Financial Results and [prnewswire.com]
REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2018 Financial Results and Recent Operational Highlights [prnewswire.com]
Research Report Identifies Rockwell Medical, Peoples, Cutera, Barrett Business Services, Cray, and Hawkins with Renewed Outlook ? Fundamental Analysis, Calculating Forward Movement [globenewswire.com]
Arrowhead Pharmaceuticals to Present Preclinical Data on Emerging Pipeline of RNAi Therapeutics | Business Wire [businesswire.com]
OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories [globenewswire.com]
Pulse Biosciences to Report First Quarter 2018 Financial Results and Operational Highlights | Business Wire [businesswire.com]
Pulse Biosciences to Report First Quarter 2018 Financial Results and Operational Highlights [businesswire.com]
Audentes Therapeutics Announces Presentation of Data at the 21st Annual Meeting of the American [prnewswire.com]
Audentes Therapeutics Announces Presentation of Data at the 21st Annual Meeting of the American Society of Gene and Cell Therapy [prnewswire.com]
Technical Perspectives on Biotech Stocks -- Axovant Sciences, Aytu BioScience, BeiGene, and [prnewswire.com]
Technical Perspectives on Biotech Stocks -- Axovant Sciences, Aytu BioScience, BeiGene, and Bellicum Pharma [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
